About Surrozen, Inc. 
Surrozen, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 3 Schemes (4.18%)
Foreign Institutions
Held by 10 Foreign Institutions (1.03%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
5 Million
(Quarterly Results - Mar 2026)
Net Profit:
-128 Million
Pharmaceuticals & Biotechnology
USD 219 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
3.41
86.05%
-9.29






